Citigroup’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.39M | Sell |
70,000
-155,400
| -69% | -$12.4M | ﹤0.01% | 2070 |
|
|
2025
Q4 | $21.5M | Sell |
225,400
-250,100
| -53% | -$24.5M | 0.01% | 1063 |
|
|
2025
Q3 | $46.4M | Buy |
475,500
+173,300
| +57% | +$17.9M | 0.02% | 660 |
|
|
2025
Q2 | $32.5M | Sell |
302,200
-162,800
| -35% | -$16.5M | 0.02% | 738 |
|
|
2025
Q1 | $46.9M | Sell |
465,000
-384,900
| -45% | -$38.8M | 0.02% | 574 |
|
|
2024
Q4 | $75.9M | Sell |
849,900
-4,100
| -0.5% | -$361K | 0.05% | 365 |
|
|
2024
Q3 | $71.6M | Buy |
854,000
+125,000
| +17% | +$9.85M | 0.04% | 377 |
|
|
2024
Q2 | $56.1M | Buy |
729,000
+256,000
| +54% | +$18.7M | 0.04% | 447 |
|
|
2024
Q1 | $32.4M | Buy |
473,000
+70,000
| +17% | +$4.5M | 0.02% | 662 |
|
|
2023
Q4 | $23.3M | Buy |
403,000
+280,000
| +228% | +$14.9M | 0.02% | 770 |
|
|
2023
Q3 | $6.49M | Buy |
123,000
+25,500
| +26% | +$1.34M | ﹤0.01% | 1305 |
|
|
2023
Q2 | $5.27M | Buy |
97,500
+67,500
| +225% | +$3.53M | ﹤0.01% | 1457 |
|
|
2023
Q1 | $1.5M | Buy |
+30,000
| New | +$1.41M | ﹤0.01% | 2218 |
|
|
2022
Q1 | – | Sell |
-302,500
| Closed | -$12.8M | – | 6320 |
|
|
2021
Q4 | $12.8M | Sell |
302,500
-488,500
| -62% | -$20.5M | 0.01% | 1246 |
|
|
2021
Q3 | $34.3M | Buy |
791,000
+538,500
| +213% | +$23.8M | 0.02% | 707 |
|
|
2021
Q2 | $10.8M | Hold |
252,500
| – | – | 0.01% | 1365 |
|
|
2021
Q1 | $9.76M | Buy |
252,500
+53,800
| +27% | +$2.04M | 0.01% | 1385 |
|
|
2020
Q4 | $7.14M | Buy |
198,700
+32,700
| +20% | +$1.18M | ﹤0.01% | 1824 |
|
|
2020
Q3 | $6.34M | Sell |
166,000
-59,500
| -26% | -$2.29M | ﹤0.01% | 1727 |
|
|
2020
Q2 | $7.92M | Buy |
225,500
+85,500
| +61% | +$3.08M | 0.01% | 1492 |
|
|
2020
Q1 | $4.57M | Buy |
140,000
+73,400
| +110% | +$2.87M | ﹤0.01% | 1753 |
|
|
2019
Q4 | $3.01M | Buy |
66,600
+5,000
| +8% | +$209K | ﹤0.01% | 2535 |
|
|
2019
Q3 | $2.51M | Buy |
61,600
+11,100
| +22% | +$470K | ﹤0.01% | 2619 |
|
|
2019
Q2 | $2.17M | Sell |
50,500
-105,200
| -68% | -$4.05M | ﹤0.01% | 2761 |
|
|
2019
Q1 | $5.98M | Buy |
155,700
+68,700
| +79% | +$2.62M | 0.01% | 1643 |
|
|
2018
Q4 | $3.08M | Sell |
87,000
-26,900
| -24% | -$976K | ﹤0.01% | 2280 |
|
|
2018
Q3 | $4.38M | Sell |
113,900
-16,400
| -13% | -$573K | ﹤0.01% | 1984 |
|
|
2018
Q2 | $4.26M | Buy |
130,300
+94,400
| +263% | +$2.85M | ﹤0.01% | 1990 |
|
|
2018
Q1 | $981K | Sell |
35,900
-3,100
| -8% | -$84.3K | ﹤0.01% | 3260 |
|
|
2017
Q4 | $967K | Buy |
39,000
+24,800
| +175% | +$684K | ﹤0.01% | 3371 |
|
|
2017
Q3 | $414K | Sell |
14,200
-10,500
| -43% | -$290K | ﹤0.01% | 4305 |
|
|
2017
Q2 | $685K | Sell |
24,700
-19,100
| -44% | -$507K | ﹤0.01% | 3692 |
|
|
2017
Q1 | $1.09M | Sell |
43,800
-40,000
| -48% | -$973K | ﹤0.01% | 3125 |
|
|
2016
Q4 | $1.81M | Buy |
83,800
+8,800
| +12% | +$192K | ﹤0.01% | 3067 |
|
|
2016
Q3 | $1.78M | Sell |
75,000
-500
| -0.7% | -$11.9K | ﹤0.01% | 2626 |
|
|
2016
Q2 | $1.76M | Buy |
75,500
+25,000
| +50% | +$541K | ﹤0.01% | 2427 |
|
|
2016
Q1 | $950K | Sell |
50,500
-233,900
| -82% | -$4.11M | ﹤0.01% | 3403 |
|
|
2015
Q4 | $5.24M | Buy |
284,400
+65,600
| +30% | +$1.18M | 0.01% | 1663 |
|
|
2015
Q3 | $3.59M | Sell |
218,800
-79,300
| -27% | -$1.36M | ﹤0.01% | 1946 |
|
|
2015
Q2 | $5.28M | Sell |
298,100
-65,300
| -18% | -$1.17M | ﹤0.01% | 1697 |
|
|
2015
Q1 | $6.45M | Buy |
363,400
+128,700
| +55% | +$2.03M | 0.01% | 1534 |
|
|
2014
Q4 | $3.11M | Sell |
234,700
-34,900
| -13% | -$446K | ﹤0.01% | 2151 |
|
|
2014
Q3 | $3.18M | Buy |
269,600
+199,500
| +285% | +$2.51M | ﹤0.01% | 2210 |
|
|
2014
Q2 | $895K | Buy |
70,100
+32,700
| +87% | +$425K | ﹤0.01% | 3054 |
|
|
2014
Q1 | $506K | Sell |
37,400
-267,000
| -88% | -$3.5M | ﹤0.01% | 3455 |
|
|
2013
Q4 | $3.66M | Buy |
304,400
+115,600
| +61% | +$1.37M | ﹤0.01% | 2070 |
|
|
2013
Q3 | $2.22M | Buy |
188,800
+58,600
| +45% | +$634K | ﹤0.01% | 2388 |
|
|
2013
Q2 | $1.21M | Buy |
+130,200
| New | +$1.1M | ﹤0.01% | 2743 |
|
Other funds holding BSX
VCM
VPM
Citigroup's BSX Position: Q1 2026 in Review
Citigroup increased its Boston Scientific (BSX) stake by 16% in Q1 2026, buying an estimated $17.6M and bringing the position to 1,576,640 shares worth $98.9M. The position accounts for 0.04% of the portfolio, ranked #409.
Citigroup first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $433M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Citigroup held 1,576,640 shares of Boston Scientific worth $98.9M as of Q1 2026.
- Citigroup bought 220,141 Boston Scientific shares in Q1 2026, an estimated $17.6M.
- Boston Scientific made up 0.04% of Citigroup's portfolio in Q1 2026, its #409 holding.
- Citigroup first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Boston Scientific position peaked at $433M in Q2 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.